Director, Vice Chairman, Professor, Fox Chase Cancer Center,
Mathews Journal of Cancer Science (MJCS; ISSN 2474-6797) is a leading-edge open access journal on cancer science. This peer-reviewed scholarly journal has a huge international footprint and publishes in various areas related to cancer science, e.g., cancer biology; cancer genetics; tumorigenesis; cancer progression and metastasis; preclinical, clinical, and epidemiological, treatments of different cancers, like lymphoma, sarcoma, gynecological cancer, brain tumor, colon cancer, and lung cancer. MJCS welcomes both theoretical and clinical contributions in the form of research articles, reviews, case reports, editorials, and communications. This journal serves as a high-profile forum for promoting major advances in oncology and cancer research.
MJCS primarily considers manuscripts for publication based on whether the findings of the studies can enable answering important questions relevant to naturally occurring cancers and provide information that serves as a foundation for future advancements in cancer research. This journal serves as a source of credible and authoritative information regarding all aspects of this debilitating disease that imposes both economic- and health-related burdens on individuals as well as the society.
Benefits for authors
High Visibility: Mathews Journal of Cancer Science (MJCS) follows open access policy that allows the published articles in the journal will reach across the globe.
Promotion in Social Media: Once the article is published online, we provide article alerts and regular email updates to subscribers through our social media platforms.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Cancer Science. For submission assistance contact: [email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at [email protected] or call us at +1-606-405–6566
Published : 08th October 2020
Authors : Maher Salamoon¹, Mehdi Balti², Bertrand Farnault³, Maher Saifo4, Ali Mahmoud5, Ahmad Khatib6, Manal Daghlawi7, Taisir Husein8, Mazen Kenj9, and Khaled Ghanem10
Citation : Salamoon M. (2020). The Role of Temozolomide-Irinotecan in Doxorubicin-Resistant Cell Lines of Recurrent Ewing’s Sarcoma, in A Patient Derived Orthotopic Xenograft (PDOX) with EWS-ERG Fusion and CDKN2A Loss: What Impact the Combination has in Real Life Practice?. Mathews J Cancer Sci. (5)1: 21.
Published : 29th May 2020
Authors : C-M Charlie Ma*, Xiaoming Chen, Alain Tafo, Dusica Cvetkovic, and Lili Chen
Citation : Ma CM. (2020). The Nonthermal Therapeutic Effect of Pulsed Focused Ultrasound. Mathews J Cancer Sci. (5)1: 20.
Published : 28th May 2020
Authors : Quanshi Zhang1 Guiping Xiao1, Qiyin Sun1, Jun Zeng1, Liang Wang1, Lili Chen2, and Chang-Ming Charlie Ma2*
Citation : Ma CM. (2020). Investigation of the Mechanisms of Radio-Dynamic Therapy. Mathews J Cancer Sci. (5)1: 19
Published : 12th December 2019
Authors : Zhitao Dai1, Cui Yang2,3, Wei Jiang1, Man Zhao1, Weigang Hu2,3, and Hua Ren1*
Citation : Ren H. (2019). The Impact of Normalization Isodose Line (NIDL) on Dose Distribution in Intracranial Tumors Treated with CyberKnife. Mathews J Cancer Sci. 4(2): 23.
Published : 11th December 2019
Author : Chang-Ming Charlie Ma
Citation : Ma CM. (2019). Physics and Dosimetric Principles of SRS and SBRT. Mathews J Cancer Sci. 4(2): 22
Published : 01st November 2019
Authors : Bin Wang1,2, Jianhua Ren3, Peng Zhang4, Dusica Cvetkovic1, Xiaoming Chen1, Lili Chen1, and Chang-Ming Charlie Ma1
Citation : Ma CM. (2019). An In-Vivo Study on Pulsed Low-Dose-Rate Radiotherapy for Prostate Cancer. Mathews J Cancer Sci. 4(2): 21.